findmyKOL

Rabin Niroula

Basic profile

Brown University

ORCIDNone on fileNPI
RegionProvidence, RI · NortheastSpecialtyHematology / OncologyFocusOncology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Rabin Niroula is an Oncology physician affiliated with Brown University. OpenAlex indexes 36 publications with 462 citations (h-index 8).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
36publications

Distinct works indexed by OpenAlex.

462citations

Total citations across indexed works.

8h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
3companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Industry payments

3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

3 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    60.4%
    Kinase inhibitor19%
    Jakafi40%Imatinib Mesylate28%Imbruvica19%Calquence14%
    Part D<11 patients
    BCL-2 Inhibitor15.9%
    Venclexta100%
    Part D18 patients

    + 4 more classes in this area

  • Anti-infectives

    17%
    Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor12.4%
    Valacyclovir100%
    Part D14 patients
    Fluoroquinolone Antibacterial4.6%
    Levofloxacin100%
    Part D11 patients
  • Metabolism & gastrointestinal

    9.5%
    Corticosteroid5.5%
    Prednisone100%
    Part D<11 patients
    Serotonin-3 Receptor Antagonist4%
    Ondansetron Hcl100%
    Part D14 patients
Where care is delivered (Part B)36.3% facility · 63.7% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”